Kingchem (Liaoning) Life Science Co., Ltd.

SZSE:301509 Stock Report

Market Cap: CN¥3.4b

Kingchem (Liaoning) Life Science Balance Sheet Health

Financial Health criteria checks 6/6

Kingchem (Liaoning) Life Science has a total shareholder equity of CN¥2.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.3B and CN¥145.9M respectively. Kingchem (Liaoning) Life Science's EBIT is CN¥90.2M making its interest coverage ratio -6.2. It has cash and short-term investments of CN¥1.4B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-6.2x
CashCN¥1.44b
EquityCN¥2.14b
Total liabilitiesCN¥145.86m
Total assetsCN¥2.28b

Recent financial health updates

Recent updates

We Think Kingchem (Liaoning) Life Science (SZSE:301509) Can Stay On Top Of Its Debt

Feb 27
We Think Kingchem (Liaoning) Life Science (SZSE:301509) Can Stay On Top Of Its Debt

Financial Position Analysis

Short Term Liabilities: 301509's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥126.0M).

Long Term Liabilities: 301509's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥19.9M).


Debt to Equity History and Analysis

Debt Level: 301509 is debt free.

Reducing Debt: 301509 has no debt compared to 5 years ago when its debt to equity ratio was 28.6%.

Debt Coverage: 301509 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 301509 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies